Renal cell carcinoma: evolving approaches to advanced non-clear cell carcinoma

Renal cell carcinoma: evolving approaches to advanced non-clear cell carcinoma

Show other versions (1)

The treatment of metastatic renal cell carcinoma (RCC) has changed dramatically with the introduction of targeted therapies including sunitinib, sorafenib, and temsirolimus. Because patients with conventional clear cell histology account for 75- 80% of all patients with RCC, there has been little ac...

Full description

Bibliographic Details
Main Authors: Daniel Y.C. Heng, Ronald M. Bukowski
Format: Article
Language:English
Published: Frontiers Media S.A. 2011-12-01
Series:Oncology Reviews
Subjects:
Renal cell cancer - Non-clear cell - Papillary - Chromophobe - Collecting duct - Sunitinib - Sorafenib - Temsirolimus
Online Access:http://oncologyreviews.org/index.php/or/article/view/152

Similar Items

Similar Items